Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 25, 2012
[Perspective of proteomic studies for discovering biomarkers of diabetes and obesity]Yasushi Kaburagi, Hiroyuki Unoki-Kubota
Bioscience Trends|November 15, 2016
A novel angiogenic peptide, ΔADT: A truncated adrenotensin peptide revealed by secretory peptidome analysis of human retinal pericytesAkinori Okumura, Eri Takahashi, Hiroyuki Unoki-Kubota, et al.
Protein and Peptide Letters|May 6, 2010
Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic miceHiroyuki Unoki-Kubota, Sho-ichi Yamagishi, Masayoshi Takeuchi, et al.
Bioscience Trends|January 7, 2014
Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liverAkinori Okumura, Hiroyuki Unoki-Kubota, Yumi Matsushita, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 21, 2022
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19Masahiro Ishikane, Hiroyuki Unoki-Kubota, Ataru Moriya, et al.
Nature Communications|November 23, 2016
The GCN5-CITED2-PKA signalling module controls hepatic glucose metabolism through a cAMP-induced substrate switchMashito Sakai, Tomoko Tujimura-Hayakawa, Takashi Yagi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 7, 2016
Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathyAkinori Okumura, Hiroyuki Unoki-Kubota, Natsuyo Yoshida-Hata, et al.
Pageof 2